Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franziska Rodner

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|June 15, 2026
MEK1/2 inhibitor ATR-002 reshapes host transcriptome and modulates immune regulatory genes in SARS-CoV-2 infectionFranziska Rodner, Klaus Schughart, Stephan Ludwig, et al.
Antiviral Research|March 4, 2024
The host-targeted antiviral drug Zapnometinib exhibits a high barrier to the development of SARS-CoV-2 resistanceAndré Schreiber, Franziska Rodner, Nicole Oberberg, et al.
Emerging Microbes & Infections|February 20, 2025
Influenza H5Nx viruses are susceptible to MEK1/2 inhibition by zapnometinibAndré Schreiber, Nicole Oberberg, Benjamin Ambrosy, et al.
Journal of Psychiatric Research|April 7, 2022
Immunological changes following electroconvulsive therapy in multiple sclerosisErhan Kavakbasi, Franziska Rodner, Lavanja Nimalavachchlan, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|June 15, 2026
MEK1/2 inhibitor ATR-002 reshapes host transcriptome and modulates immune regulatory genes in SARS-CoV-2 infectionFranziska Rodner, Klaus Schughart, Stephan Ludwig, et al.
Antiviral Research|March 4, 2024
The host-targeted antiviral drug Zapnometinib exhibits a high barrier to the development of SARS-CoV-2 resistanceAndré Schreiber, Franziska Rodner, Nicole Oberberg, et al.
Emerging Microbes & Infections|February 20, 2025
Influenza H5Nx viruses are susceptible to MEK1/2 inhibition by zapnometinibAndré Schreiber, Nicole Oberberg, Benjamin Ambrosy, et al.
Journal of Psychiatric Research|April 7, 2022
Immunological changes following electroconvulsive therapy in multiple sclerosisErhan Kavakbasi, Franziska Rodner, Lavanja Nimalavachchlan, et al.
Pageof 1